PHOENIX, AZ – The US Food and Drug Administration would like to adopt an annual update process for the COVID-19 vaccine, according to Peter Marks, director of the Center for Biologics Evaluation and Research (CBER). Such a process he said will help health officials, manufacturers and others better coordinate efforts to fight the SARS-CoV-2 virus as it evolves.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,